INCREASED LEVEL OF DIHYDROFOLIC REDUCTASE IN LEUCOCYTES OF PATIENTS TREATED WITH AMETHOPTERIN
INCREASED LEVEL OF DIHYDROFOLIC REDUCTASE IN LEUCOCYTES OF PATIENTS TREATED WITH AMETHOPTERIN
复制标题
DOI:
10.1038/193140a0
复制
发表时间:
1962-01-01
期刊:
影响因子:
64.8
通讯作者:
GABRIO, BW
中科院分区:
文献类型:
--
作者:
BERTINO, JR;HUENNEKENS, FM;GABRIO, BW
Aug Sept.| Ocf.| Nộy.| Dec. amethopterin _ to produce any appreciable effect indicated that Fig. 1. The scale for chemotherapeutic dosages refers only to amethopterin. Actual values the leucocytes of the patient had for the other agents were: 6-mercaptopurine, 300 mgm. jday for nine days; prednisone, 80, 40 and 20 Ingm, on three successive days; dichloroamethopterin, 25 mgm. jday (intravenous) for two days; and chloromycetin, 2 mgm./day for five days resistance in patients undergoing treatment with amethopterin. The level of dihydrofolic reductase has been followed in a number of patients during the course of treatment with amethopterin". Typical results for a patient with acute myeloblastic leukæmia are shown in Fig. 1. Before the work reported here, the patient had experienced a partial remission, lasting for about four months, on being treated with 6-mercaptopurine. In addition to white cell count, therapy and reductase-level, values are also shown for the level of formate-activating enzyme, another folic acid-dependent system. Following an initial course of amethopterin, the white count dropped rapidly to a level of 3,000 and was maintained for about three weeks with additional chemotherapy. Gastro-intestinal toxicity, as indicated by vertical arrows on the chart, necessitated the interruption of therapy. During this period of partial remission, there was a decrease in blast forms from 95 per cent to 20 per cent and a rise in the hæmatocrit and in platelet count. Concomitantly, a six-fold increase was observed in the level of dihydro-